Karkas, Réka and Abdullah, Khaldoon Sadiq Ahmed and Kaizer, László and Ürmös, A and Raya, May and Tiszlavicz, Lilla Györgyi and Pankotai, Tibor and Nagy, István and Mátés, Lajos and Sükösd, Farkas (2025) LINE-1 ORF1p is a Promising Biomarker in Cervical Intraepithelial Neoplasia Degree Assessment. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 44 (1). pp. 22-30. ISSN 0277-1691
|
Text
line_1_orf1p_is_a_promising_biomarker_in_cervical.4.pdf - Published Version Download (789kB) | Preview |
Abstract
Cervical intraepithelial neoplasia (CIN) represents a spectrum of preinvasive squamous lesions within the cervical epithelium, whose identification is a diagnostic challenge due to subtle histomorphological differences among its categories. This study explores ORF1p, a nucleic acid-binding protein derived from long interspersed nuclear element-1 (LINE-1), as a potential biomarker for enhancing CIN diagnosis. A comprehensive analysis of 143 cervical specimens, encompassing CIN I (n=20), CIN II (n=46), CIN III (n=14), invasive cancer (n=32), and nondysplastic cases (normal cervical epithelia (n=24) and atrophy (n=7) were conducted. ORF1p, Ki67, and p16 expressions were evaluated using immunohistochemistry. ORF1p immunopositivity was detected in the vast majority [110/112 (98.2%)] of dysplastic and neoplastic (CIN and invasive cancer) specimens, whereas 19/24 (79.2%) of normal cervical specimens lacked ORF1p expression. The observed pattern of ORF1p expression showed a progressively increasing extent and intensity with advancing CIN grades. CIN I exhibited mild ORF1p expression in the lower one or two-thirds of the cervical epithelium [14/16 (87.5%)], whereas CIN II demonstrated moderate to strong ORF1p expression spanning the lower two-thirds [29/46 (63.0%)]. Pronounced transepithelial ORF1p immunopositivity characterized CIN III cases [13/14 (92.8%)] and cervical cancer [30/32 (93.8%)]. These findings propose ORF1p as a valuable indicator even for detecting CIN I, effectively discerning them from normal cervical tissue (p < 0.0001). Our findings underscore the potential of ORF1p as an early diagnostic marker for cervical neoplasia.
| Item Type: | Article |
|---|---|
| Additional Information: | Funding Agency and Grant Number: National Research, Development and Innovation Fund, Hungary [2021-1.1.4-GYORSITOSAV- 2022-00018]; New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development, and Innovation Fund, Hungary [UNKP-23-3] Funding text: The project was, in part, funded by the 2021-1.1.4-GYORSITOSAV- 2022-00018 project of the National Research, Development and Innovation Fund, Hungary. R.K. was supported by the UNKP-23-3 New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development, and Innovation Fund, Hungary. |
| Uncontrolled Keywords: | cervical intraepithelial neoplasia, diagnostic biomarker, ORF1p, LINE-1, carcinogenesis |
| Subjects: | R Medicine / orvostudomány > RB Pathology / patológia, kórtan |
| SWORD Depositor: | MTMT SWORD |
| Depositing User: | MTMT SWORD |
| Date Deposited: | 11 Mar 2026 11:52 |
| Last Modified: | 11 Mar 2026 11:52 |
| URI: | https://real.mtak.hu/id/eprint/235551 |
Actions (login required)
![]() |
Edit Item |




